In the context of myocardial fibrosis, Wang et al. reported that metformin can counteract the TGF-β1–Smad3 signaling pathway including TGF-β1 production, phosphorylation of Smad3 and nuclear translocation of Smad3 [31]. This evidence concerns the gene SMAD3 and Myocardial fibrosis.